default image

Belegabteilung für Urologie

Information and services of the department

  • Number of inpatient cases: 114

Services search (in the department)


Illness Number of cases
Hyperplasia of prostate (N40) 18
Malignant neoplasm of bladder - Malignant neoplasm of overlapping sites of bladder (C67.8) 15
Hydrocele and spermatocele - Other hydrocele (N43.2) 11
Obstructive and reflux uropathy (N13.3) 10
Neoplasm of uncertain or unknown behaviour of urinary organs - Neoplasm of uncertain behavior of bladder (D41.4) 8
Malignant neoplasm of prostate (C61) 4
Malignant neoplasm of bladder - Malignant neoplasm of bladder neck (C67.5) 4
Obstructive and reflux uropathy - Hydronephrosis with ureteral stricture not elsewhere classified (N13.1) 4
Malignant neoplasm of ureter (C66) not specified
Malignant neoplasm of bladder - Malignant neoplasm of dome of bladder (C67.1) not specified
Treatment Number
Injection or administration of medicines into the urinary bladder (8-132.3) 66
X-rays of the kidney and urinary tract with contrast medium (3-13d.5) 32
Surgical incision, removal or destruction of diseased tissue in the urinary bladder, with access through the urethra (5-573.41) 30
Insertion, exchange or removal of a ureteral stent (8-137.10) 24
Surgical creation of a connection between the urinary bladder and skin of the abdomen for artificial urinary drainage (5-572.1) 14
Surgical incision into diseased tissue in the urethra, with access through the urethra (5-585.1) 13
Surgical removal or destruction of prostatic tissue through the urethra (5-601.1) 13
Surgical occlusion of a hydrocele on the testicle (5-611) 13
Surgical removal or destruction of prostatic tissue through the urethra (5-601.0) 12
Surgical incision, removal or destruction of diseased tissue in the urinary bladder, with access through the urethra (5-573.1) 10

Hospital information and services for all specialist departments

External comparative quality assurance
Further information
  • External quality assurance according to state law
    No participation
  • Quality of participation in the Disease Management Programme (DMP)
    No participation
  • Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)
    No participation
Number Group
16 Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
13 Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
13 Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations
* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Jürgen Stern

Patientenfürsprecher

Phone: 0991 -380-1116
Mail: ed.mukinilk-rasi-uanod@nrets.negreuj

Cornelia Wohlhüter

Patientenfürsprecher

Phone: 0991 -380-1294
Mail: ed.mukinilk-rasi-uanod@ehcarpsreufnetneitap

Jürgen Stern

Marketing und Öffentlichkeitsarbeit

Phone: 0991 -380-1116
Mail: ed.mukinilk-rasi-uanod@nrets.negreuj

Michael Kappl

Qualitätsmanagement und Prozessgestaltung

Phone: 0991 -380-1293
Mail: ed.mukinilk-rasi-uanod@lppak.leahcim

Dr. med. Josef Bayerl

Chefarzt

Phone: 0991 -380-3300
Mail: ed.mukinilk-rasi-uanod@lreyab.fesoj